In a riveting discussion, Vikas Dandekar, a pharma leader with deep insights into antimicrobial resistance, teams up with Dr. Manica Balasegaram, the Executive Director of the Global Antibiotic R&D Partnership. They delve into India's alarming antibiotic misuse and its implications on global health. The duo emphasizes the urgent need for better regulations and public awareness. They also explore innovative strategies for antibiotic development and stress the importance of global collaboration to combat this escalating crisis.
The misuse of over-the-counter antibiotics in India has become a severe public health issue, contributing significantly to rising antimicrobial resistance (AMR).
Global efforts to combat AMR are currently fragmented, highlighting the need for coordinated actions and investment, especially from low- and middle-income countries.
Deep dives
Misuse of Antibiotics in India
The over-the-counter availability and misuse of antibiotics in India has led to a significant public health challenge. Many individuals resort to self-medication, taking antibiotics like azithromycin or augmentin without appropriate medical guidance, which contributes to the rise of antimicrobial resistance (AMR). The widespread practice of prescribing antibiotics for ailments that may not require them exacerbates the issue, particularly in smaller cities and rural areas. Experts highlight the pressing need for regulatory controls and public awareness to curb this alarming trend, emphasizing that this is a global issue, not just confined to India.
Global Responses and Initiatives
Global efforts to tackle antimicrobial resistance have been described as fragmented, with varying levels of commitment from different countries. The WHO has acknowledged AMR as a pressing concern, with millions of deaths linked to antibiotic resistance annually. Recently, at the United Nations General Assembly, new guidelines aimed at reducing AMR-related deaths by 10% each year by 2030 were established, signaling a more coordinated international approach. However, investment in research and development remains a challenge, particularly for low- and middle-income countries, where the burden of resistant infections is often highest.
The Role of India in Addressing AMR
India has the potential to play a crucial role in combating antimicrobial resistance due to its extensive pharmaceutical capabilities and experience in producing affordable medicines. Experts argue that India should shift its perspective from viewing the problem solely as a national issue to embracing a global responsibility, leveraging its strengths to contribute to international efforts. Collaborative partnerships with organizations focused on antibiotic research and development can enhance India’s role in addressing AMR. Additionally, improved access to antibiotics and reduced unnecessary prescriptions are essential steps to mitigate the growing threat of AMR in the country and globally.
Antimicrobial Resistance (AMR) is escalating into a global health emergency, with dire consequences for humanity. As World AMR Awareness Week unfolds, Anirban Chowdhury hosts an insightful conversation with Vikas Dandekar and Dr. Manica Balasegaram, Executive Director at the Global Antibiotic R&D Partnership. Together, they explore the global response, innovative solutions, and India’s potential influence in combating this looming crisis.
Tune in!
ET Podcasts now has a new show. 7@7 is your quick, sharp sub 5 minute daily roundup of financial news from India and the world. Tune in to Apple Podcasts, Spotify, Amazon Prime Music, Jio Saavn, Youtube or wherever you get your podcasts from!